While AI has the potential to move medical sciences forward at historic velocity, these advances will only be realized if the infrastructure built to safely bring these products to market can also move at modern speed. Experts in these areas will tell you that this might be the harder challenge of the two types! That is why we’re excited to see startups like Peppermint working to solve clinical research challenges -- now with a $4.7 million seed round to help fuel the growth.
Peppermint streamlines financial operations and accelerates growth for clinical research teams. Despite advances in the science and technology driving novel drug development, the industry still relies on an antiquated and fragmented financial framework. Instead of payments flowing smoothly between sponsors, CROs, health systems, and research sites, clinical research relies on a patchwork of systems that were never designed to work together. Every party absorbs the cost of that complexity.
When we first met Peppermint’s founders David and Vijay, it was clear their combined backgrounds supported both broad systems thinking and a move quickly attitude. Already they’ve tripled the number of studies under management during the prior three months, delivering on average 3x revenue collection speed and 20% clinical time saved. And they’re just getting started.
Homebrew is happy to be a supporting investor of Peppermint and if you’re a site, network, or hospital system performing clinical research, please reach out.
